Cargando…
Axonal loss at time of diagnosis as biomarker for long‐term disability in chronic inflammatory demyelinating polyneuropathy
INTRODUCTION/AIMS: We hypothesized that early, pretreatment axonal loss would predict long‐term disability, supported by a pilot study of selected patients with chronic inflammatory demyelinating polyneuropathy (CIDP). To further test this hypothesis, we examined a larger consecutive group of CIDP p...
Autores principales: | Al‐Zuhairy, Ali, Jakobsen, Johannes, Moldovan, Mihai, Krarup, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828077/ https://www.ncbi.nlm.nih.gov/pubmed/36217677 http://dx.doi.org/10.1002/mus.27722 |
Ejemplares similares
-
Challenges in the diagnosis of chronic inflammatory demyelinating polyneuropathy
por: Allen, Jeffrey A., et al.
Publicado: (2018) -
Dilemmas in Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy: A New Axonal Variant?
por: Sharma, Sanjiv, et al.
Publicado: (2022) -
Depression with Chronic Inflammatory Demyelinating Polyneuropathy
por: Marwale, Arun, et al.
Publicado: (2018) -
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021) -
Loss of Schwann cell plasticity in chronic inflammatory demyelinating polyneuropathy (CIDP)
por: Joshi, Abhijeet R., et al.
Publicado: (2016)